Keros TherapeuticsInc Net Worth
Keros TherapeuticsInc Net Worth Breakdown | KROS |
Keros TherapeuticsInc Net Worth Analysis
Keros TherapeuticsInc's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Keros TherapeuticsInc's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Keros TherapeuticsInc's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Keros TherapeuticsInc's net worth analysis. One common approach is to calculate Keros TherapeuticsInc's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Keros TherapeuticsInc's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Keros TherapeuticsInc's net worth. This approach calculates the present value of Keros TherapeuticsInc's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Keros TherapeuticsInc's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Keros TherapeuticsInc's net worth. This involves comparing Keros TherapeuticsInc's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Keros TherapeuticsInc's net worth relative to its peers.
Enterprise Value |
|
To determine if Keros TherapeuticsInc is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Keros TherapeuticsInc's net worth research are outlined below:
| Keros TherapeuticsInc generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 151 K. Net Loss for the year was (152.99 M) with loss before overhead, payroll, taxes, and interest of (87.27 M). | |
| Keros TherapeuticsInc currently holds about 215.62 M in cash with (124.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.37. | |
| Over 94.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Keros Therapeutics, Inc. Upgraded to Buy Heres What You Should Know - Yahoo Canada Shine On |
Keros TherapeuticsInc uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Keros TherapeuticsInc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Keros TherapeuticsInc's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 1st of March 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 1st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Keros TherapeuticsInc's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Keros TherapeuticsInc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Keros TherapeuticsInc backward and forwards among themselves. Keros TherapeuticsInc's institutional investor refers to the entity that pools money to purchase Keros TherapeuticsInc's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Franklin Resources Inc | 2023-12-31 | 699.4 K | Adar1 Capital Management Llc | 2023-12-31 | 688.3 K | Eventide Asset Management, Llc | 2024-03-31 | 680 K | Candriam Luxembourg S.c.a. | 2024-03-31 | 652 K | Holocene Advisors, Lp | 2024-03-31 | 638 K | Geode Capital Management, Llc | 2024-03-31 | 595.8 K | Redmile Group, Llc | 2024-03-31 | 552.5 K | Opaleye Management Inc | 2024-03-31 | 367.5 K | Millennium Management Llc | 2024-03-31 | 337.7 K | Fmr Inc | 2024-03-31 | 5 M | Blackrock Inc | 2024-03-31 | 2.2 M |
Follow Keros TherapeuticsInc's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.69 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Keros TherapeuticsInc's market, we take the total number of its shares issued and multiply it by Keros TherapeuticsInc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Market Cap |
|
Project Keros TherapeuticsInc's profitablity
Keros TherapeuticsInc's profitability indicators refer to fundamental financial ratios that showcase Keros TherapeuticsInc's ability to generate income relative to its revenue or operating costs. If, let's say, Keros TherapeuticsInc is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Keros TherapeuticsInc's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Keros TherapeuticsInc's profitability requires more research than a typical breakdown of Keros TherapeuticsInc's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.41) | (0.43) | |
| Return On Capital Employed | (0.49) | (0.52) | |
| Return On Assets | (0.41) | (0.43) | |
| Return On Equity | (0.46) | (0.48) |
When accessing Keros TherapeuticsInc's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Keros TherapeuticsInc's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Keros TherapeuticsInc's profitability and make more informed investment decisions.
The data published in Keros TherapeuticsInc's official financial statements usually reflect Keros TherapeuticsInc's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Keros TherapeuticsInc. For example, before you start analyzing numbers published by Keros accountants, it's critical to develop an understanding of what Keros TherapeuticsInc's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Keros TherapeuticsInc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Keros TherapeuticsInc's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Keros TherapeuticsInc's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Keros TherapeuticsInc. Please utilize our Beneish M Score to check the likelihood of Keros TherapeuticsInc's management manipulating its earnings.
Evaluate Keros TherapeuticsInc's management efficiency
Keros TherapeuticsInc has return on total asset (ROA) of (0.2579) % which means that it has lost $0.2579 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3963) %, meaning that it created substantial loss on money invested by shareholders. Keros TherapeuticsInc's management efficiency ratios could be used to measure how well Keros TherapeuticsInc manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.43 in 2024. Return On Capital Employed is likely to drop to -0.52 in 2024. At this time, Keros TherapeuticsInc's Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 2.2 M in 2024, whereas Net Tangible Assets are likely to drop slightly above 166.3 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 11.28 | 6.88 | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | 11.28 | 6.88 | |
| Enterprise Value Over EBITDA | (5.12) | (5.37) | |
| Price Book Value Ratio | 3.52 | 3.35 | |
| Enterprise Value Multiple | (5.12) | (5.37) | |
| Price Fair Value | 3.52 | 3.35 | |
| Enterprise Value | 854.1 M | 545.9 M |
The analysis of Keros TherapeuticsInc's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Keros TherapeuticsInc's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Keros Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Enterprise Value Revenue 11.9 K | Revenue 234 K | Revenue Per Share 0.007 | Return On Equity (0.40) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Keros TherapeuticsInc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Keros TherapeuticsInc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Keros TherapeuticsInc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Keros TherapeuticsInc Corporate Filings
8K | 30th of May 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
ASR | 3rd of May 2024 Automatic Shelf Registration Statement under Rule 415 filed with the U.S. Securities and Exchange Commission (SEC) | ViewVerify |
| 17th of April 2024 Other Reports | ViewVerify | |
| 29th of February 2024 Other Reports | ViewVerify |
Keros TherapeuticsInc Earnings per Share Projection vs Actual
Be your own money manager
Our tools can tell you how much better you can do entering a position in Keros TherapeuticsInc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Keros TherapeuticsInc Corporate Management
Elected by the shareholders, the Keros TherapeuticsInc's board of directors comprises two types of representatives: Keros TherapeuticsInc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Keros. The board's role is to monitor Keros TherapeuticsInc's management team and ensure that shareholders' interests are well served. Keros TherapeuticsInc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Keros TherapeuticsInc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robin Wagner | Senior Resources | Profile | |
| Simon MBBS | Chief Officer | Profile | |
| Keith MBA | Chief Officer | Profile | |
| Christopher MSc | Chief Officer | Profile | |
| John MBA | Senior Management | Profile | |
| Jennifer Lachey | Chief Officer | Profile | |
| Jasbir Seehra | CEO and President | Profile |
How to buy Keros Stock?
The net worth of Keros TherapeuticsInc is the difference between its total assets and liabilities. Keros TherapeuticsInc's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Keros TherapeuticsInc's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Keros TherapeuticsInc's net worth can be used as a measure of its financial health and stability which can help investors to decide if Keros TherapeuticsInc is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Keros TherapeuticsInc stock.Already Invested in Keros TherapeuticsInc?
The danger of trading Keros TherapeuticsInc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Keros TherapeuticsInc is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Keros TherapeuticsInc. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Keros TherapeuticsInc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Keros TherapeuticsInc is a strong investment it is important to analyze Keros TherapeuticsInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Keros TherapeuticsInc's future performance. For an informed investment choice regarding Keros Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Keros TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Keros Stock please use our How to Invest in Keros TherapeuticsInc guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Keros Stock analysis
When running Keros TherapeuticsInc's price analysis, check to measure Keros TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Keros TherapeuticsInc is operating at the current time. Most of Keros TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Keros TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Keros TherapeuticsInc's price. Additionally, you may evaluate how the addition of Keros TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is Keros TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Keros TherapeuticsInc. If investors know Keros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Keros TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.15) | Revenue Per Share 0.007 | Return On Assets (0.26) | Return On Equity (0.40) |
The market value of Keros TherapeuticsInc is measured differently than its book value, which is the value of Keros that is recorded on the company's balance sheet. Investors also form their own opinion of Keros TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Keros TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Keros TherapeuticsInc's market value can be influenced by many factors that don't directly affect Keros TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Keros TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Keros TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Keros TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.